N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. by Noelia Carballeda-Sangiao (2889611)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. by Kameljit K. Kalsi (16496511)

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Raw data used to calculate the statistical significances stated in the result section. by Tom Adriaenssens (397863)

Subjects:

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…Samples were separated based on clinical outcome (X-axis, orange treatment responsive, teal treatment non-responsive). …”

Table1_Clinical Significance of TET2 in Female Cancers.docx by Fang Wan (779615)

“…Therefore, this study aimed to summarize the clinical value and underlying oncogenic functions of TET2 in female cancers, such as breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), ovarian serous cystadenocarcinoma (OV), uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS), based on the data obtained from The Cancer Genome Atlas. …”

The significance of variation in cortical trabecular bone stiffness between specimens. by Linje Wang (18064951)

Subjects:

The significance of variation in cortical bone elastic modulus within a region. by Linje Wang (18064951)

Subjects:

Descriptive statistics based on type of therapy and time of assessment. by Nina Brkić-Jovanović (18886883)

Subjects:

Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

“…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”

Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period. by Faran Sabeti (6166766)

Subjects:

Quantitative Venn diagram of proteins expressed in sera of patients with clinically significant portal hypertension (CSPH) and non-CSPH group. by Frane Pastrovic (18349349)

Clinical and demographic characteristics of SSc patients and controls. by Jing Mao (148640)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects: